Business News • PR NewsWire • AbbVie to Present Detailed Phase III Results from SAPPHIRE-I and SAPPHIRE-II Studies in Chronic Hepatitis C Patients at the 2014 International Liver Congress™

AbbVie to Present Detailed Phase III Results from SAPPHIRE-I and SAPPHIRE-II Studies in Chronic Hepatitis C Patients at the 2014 International Liver Congress™

AbbVie to Present Detailed Phase III Results from SAPPHIRE-I and SAPPHIRE-II Studies in Chronic Hepatitis C Patients at the 2014 International Liver Congress™

LONDON, April 11, 2014 /PRNewswire/ -- AbbVie (NYSE: ABBV) announced that detailed results from its phase III pivotal study, SAPPHIRE-I, will be presented today at the International Liver Congress™ (ILC) 2014 and featured in the ILC press conference....

View More : http://www.prnewswire.com/news-releases/abbvie-to-present-detailed-phase-iii-results-from-sapphire-i-and-sapphire-ii-stu...

Releted News by prnewswire

New Data Show How Hepatic Encephalopathy Contributes to Burden of Liver Disease

Arctic15 Startup Conference Looks to Boost Successful Tech Acquisitions in the Region